- Home
- SRL vs CRVO Comparison
SRL vs CRVO Comparison
Compare SRL & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRL
- CRVO
- Stock Information
- Founded
- SRL 2017
- CRVO 2001
- Country
- SRL China
- CRVO United States
- Employees
- SRL N/A
- CRVO N/A
- Industry
- SRL Professional Services
- CRVO Biotechnology: Pharmaceutical Preparations
- Sector
- SRL Consumer Discretionary
- CRVO Health Care
- Exchange
- SRL Nasdaq
- CRVO Nasdaq
- Market Cap
- SRL 122.8M
- CRVO 98.3M
- IPO Year
- SRL N/A
- CRVO N/A
- Fundamental
- Price
- SRL $8.02
- CRVO $2.11
- Analyst Decision
- SRL
- CRVO Buy
- Analyst Count
- SRL 0
- CRVO 8
- Target Price
- SRL N/A
- CRVO $38.75
- AVG Volume (30 Days)
- SRL 19.1K
- CRVO 303.4K
- Earning Date
- SRL 12-31-2024
- CRVO 11-12-2024
- Dividend Yield
- SRL N/A
- CRVO N/A
- EPS Growth
- SRL N/A
- CRVO N/A
- EPS
- SRL N/A
- CRVO N/A
- Revenue
- SRL $33,997,735.00
- CRVO $10,066,550.00
- Revenue This Year
- SRL N/A
- CRVO $34.17
- Revenue Next Year
- SRL N/A
- CRVO N/A
- P/E Ratio
- SRL N/A
- CRVO N/A
- Revenue Growth
- SRL N/A
- CRVO 116.29
- 52 Week Low
- SRL $5.74
- CRVO $1.80
- 52 Week High
- SRL $9.99
- CRVO $26.38
- Technical
- Relative Strength Index (RSI)
- SRL 53.27
- CRVO 28.68
- Support Level
- SRL $7.93
- CRVO $2.03
- Resistance Level
- SRL $8.39
- CRVO $2.17
- Average True Range (ATR)
- SRL 0.65
- CRVO 0.16
- MACD
- SRL 0.04
- CRVO 0.30
- Stochastic Oscillator
- SRL 46.76
- CRVO 23.08
About SRL Scully Royalty Ltd.
Scully Royalty Ltd is a royalty-based company that maximizes earnings upon its iron ore royalty interest. The company's business segments include Royalty, which includes an interest in an iron ore mine; Industrial, which includes projects in resources and services; Merchant Banking, which comprises regulated merchant banking activities; and others. The majority of the revenue is generated from the Royalty segment. The company's geographical segments include Canada, Africa, America, Asia, and Europe, out of which Canada accounts for the majority of the revenue.
About CRVO CervoMed Inc.
CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.